Join Jessica Quimby on Wednesday June 12th from 19:00-20:00 (GMT) for the second instalment in Dechra’s feline chronic kidney disease (CKD) webinar series.
In this webinar, Jess will be looking will be looking into what is important and why when faced with diagnosing a cat who potentially has CKD.
To register for this event, please click the link - https://lnkd.in/e_A9gZ6g
See you there!
#Webinar#Dechra#Veterinary
🚀 Dechra is thrilled to be sponsoring the Innovation Theatre at the 2024 Singapore Vet Show! As Asia’s premier veterinary conference and exhibition, this event brings together professionals and leaders in animal health from across the globe.
🗓️ Dates: 25th – 26th October, 2024
📍 Location: Suntec Singapore.
With over 110 exhibitors from 37+ countries and a diverse conference program, the Singapore Vet Show offers invaluable insights into the latest developments in clinical best practices, research, technology, and business strategies in the veterinary industry.
At Dechra, innovation is at the core of what we do. Our recent acquisition of Invetx, a biotechnology company pioneering long-acting monoclonal antibodies (mAbs), reaffirms our dedication to improving clinical outcomes and animal welfare. The Innovation Theatre will host engaging discussions on topics such as gut health and tick-borne diseases.
We’re also proud to have Ceri Bailey, our Veterinary Technical Manager, present two seminars showcasing Dechra’s cutting-edge tools like the 4D Ear Model, Cushing’s Clinical Score, and Endocrinology App.
25th October 2024
🕘 9:45 AM - 10:35 AM
Cultivating a Lifelong Ear Partnership: Improving otitis externa outcomes
26th October 2024
🕘 9:45 AM - 10:35 AM
Cushing’s Chronicles: Insights from 20 years of Vetoryl
Ceri will be joined by Pedro Cardoso, our Regional Account Manager. If you're attending the congress, we’d love to connect! Feel free to reach out at technical.international@dechra.com to arrange a meeting.
Find out more: https://brnw.ch/21wNlwc
We can't wait to see you there! 👋
#SingaporeVetShow#Dechra#VeterinaryInnovation#AnimalHealth#TheVeterinaryPerspective#Singapore
📢 Exciting News! New Appointment Announcement 📢
We are delighted to announce the appointment of Laura Olsen as our new, President, of North America. Laura will join us in early September, bringing a wealth of experience in animal and human health, having previously worked at Zoetis, Pfizer, and Novartis.
Laura has consistently delivered impressive business results and has a proven track record of developing and empowering colleagues throughout her 25 year career. Her experience will be invaluable as we continue to shape and invest in our future.
Please join us in welcoming Laura to the Dechra team!
#Leadership#NewAppointment#Welcome#Dechra
🎉Dechra acquires innovative companion animal insulin programs from partner Akston Biosciences 🎉
With our established expertise in endocrinology, these programs strengthen our portfolio and are a great example of our commitment to improving animal health and welfare through innovation. The long acting insulins have the potential to lower the treatment burden on both the pets being treated and the owners who care for them, making us excited about the impact these cutting-edge treatments can have. We look forward to developing these diabetes treatments for dogs and cats over the coming years as part of our strategy to be an innovation leader in companion animal therapeutics.
#Dechra#TheVeterinaryPerspective#AnimalHealth#Endocrinology#CompanionAnimals#Innovation
🎉Exciting News: Dechra announces upcoming acquisition of Invetx 🎉
Invetx is a pioneer in creating novel, protein-based animal health therapeutics for chronic conditions in companion animals, with a focus on monoclonal antibodies (mAbs).
The acquisition secures an exciting pipeline of innovative products for dogs and cats which are highly complementary to our broad portfolio of speciality therapeutics, and provides entry into the large and high growth mAbs market. It adds new technology capability, bolsters our existing pipeline and provides a significant runway for future growth.
Jesper Nordengaard, recently appointed Chief Executive Officer of Dechra, said "I regard this acquisition as hugely important for Dechra, marking the start of a new chapter in our growth. It demonstrates our ambition to create further points of differentiation and relevance with veterinarians and pet owners alike and confidence in our ability to deliver highly innovative new products."
Read the full article: https://lnkd.in/eUqFQEBR#CompanyAcquisition#BusinessGrowth#Innovation#ExcitingTimes#TheVeterinaryPerspective
And that's a wrap on the 2024 Not One More Vet Race Around the World!
This May, Dechra was proud to sponsor and participate in Not One More Vet's annual fundraising event in support of their mission to transform the status of mental wellness in the veterinary profession.
We had over 750 team members from 24 countries register for the race, making it a truly global event, and raised over $13,000 for NOMV as a result!
Not only did race participation support a great cause, but we had fun and boosted our own physical and mental health as well. Team members participated in the race both individually and in groups by walking, biking, hiking, running, horseback riding, and more!
Even though this year's Race Around the World may be over, Dechra looks forward to continuing our unique and impactful partnership with NOMV in many ways.
#DechraTeam#RATW24#NotOneMoreVet
Dechra is proud to announce that our net-zero science-based targets have been validated by @ScienceTargets #NetZeroStandard.
Following the approval of our near-term science-based targets, the Target Validation Team has evaluated Dechra's scope 1, 2, and 3 long-term target ambition and determined that our long-term targets are aligned with the SBTi's 1.5°C mitigation pathways for reaching net-zero by 2050 or sooner.
With this approval, Dechra commits to reduce absolute scope 1 and 2 greenhouse (GHG) emissions 90% by latest 2050 from a 2021 base year. We also commit to reduce scope 3 GHG emissions 97% per GBP value added within the same timeframe.
Dechra knows the world must reach #NetZero no later than 2050, and companies have a crucial part to play. We’re proving our commitment to building a sustainable world and aligning with a #NetZero future by setting science-based targets.
Dechra Europe is excited to be attending the ISFM Congress in Malta from the 27th-30th June. Visit the team in the HMCC foyer at Booth 11 to learn more about our wide range of feline medicine products & to receive your free gift!
#TheVeterinaryPerspective#Dechra
Today is World Environment Day, an occasion to inspire positive change for the environment. 🌳🌎🏞️
This year's theme focuses on land restoration, desertification, and drought resilience under the slogan “Our land. Our future. We are #GenerationRestoration.”
Agriculture’s connections to the world economy, human societies, and biodiversity make it one of the most important frontiers for conservation. Sustainable management of agriculture preserves and restores critical habitats, protects watersheds, and improves soil health and water quality.
Linked to this theme, Dechra's beyond the value chain project supports the AgCoTech facility in Laos which produces nutritional blocks for livestock.
These blocks reduce methane production in the highest emitting regions, help improve the condition of livestock, and enable developing countries to better manage food security and regional prosperity. So far, 2,036 blocks have been distributed to 204 families in need!
#Dechra#WorldEnvironmentDay#GenerationRestoration